繁體
简体中文
繁體中文

李爾 LEA

已收盤 05-08 16:00:00 美东时间

139.69

+4.400

+3.25%

华盛通華盛通
立即下載
  • 最 高139.75
  • 今 開136.15
  • 成交量 56.90万股
  • 最 低 135.56
  • 昨 收 135.29
  • 總市值 69.98亿
  • 52周最高 142.07
  • 市盈率 17.14
  • 換手率 1.14%
  • 52周最低 83.83
  • 委 比 -84.38%
  • 總股本 5009.51万
  • 歷史最高 190.30
  • 量 比 0.74
  • 振 幅 3.10%
  • 歷史最低 8.53
  • 每 手 1
  • 風險率 13.92%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • 2026年一季度11家全球汽车零部件企业财报观察

    (来源:力基咨询) 2026 年以来,全球汽车产业链处于电动化转型深化、区域市场分化明显、供应链结构持续调整的阶段,叠加上游原材料价格阶段性波动的影响...

    05-08 11:56

  • SCHMID Announces Investor Conference Call and Webcast

    SCHMID Group N.V., a global leader in advanced manufacturing solutions, will host an investor conference call and webcast on May 18, 2026, at 9:30 ET / 15:30 CEST to discuss its 2025 annual financial results and business update. The event will include a review of financial performance, key developments, and a Q&A session. Presentation materials will be available via the Company’s website and webcast. The Company also filed its Annual Report on Fo...

    05-08 08:41

  • Who Benefits As Meta Tests Stablecoin Payments For Creators

    Last week, Meta (NASDAQ:META) began paying its content creators in USDC, a dollar-backed Stablecoin, through crypto wallets on the Solana

    05-07 23:38

  • 21shares Launches TCAN, the First U.S. ETF Providing Exposure to the Canton Network

    21Shares launched the 21Shares Canton Network ETF (TCAN), the first U.S. ETF offering direct exposure to Canton Coin, the native token of the Canton Network, a privacy-enabled blockchain ecosystem supported by global institutions like Goldman Sachs, Microsoft, and Deutsche Bank. The ETF, listed on NASDAQ with a 0.50% expense ratio, aims to bridge traditional finance and decentralized innovation. Canton Network enables secure synchronization of fi...

    05-07 13:30

  • Global Study: Fueled by AI, CTV Fraud Schemes Surge 140% Globally

    DoubleVerify's 2026 Global Insights report highlights that AI is driving a surge in sophisticated CTV fraud, with schemes increasing by 140% in Q1 2026 compared to Q1 2025. Fraudsters exploit inefficiencies in the ecosystem, targeting premium CTV spend. Key findings include persistent bot activity, a 10x rise in fraudulent apps, and significant financial losses for advertisers. Fraud patterns vary by region, with bots dominating North America and...

    05-07 13:00

  • Wetherspoon Rejects Call for Two-Drink Limit in Airport Pubs

    J D Wetherspoon ( ($GB:JDW) ) has shared an announcement. J D Wetherspoon has p...

    05-07 00:12

  • Banzai Announces Reverse Stock Split

    Banzai International, Inc. will implement a 1-for-20 reverse stock split of its Class A and Class B Common Stock effective May 8, 2026. The move aims to increase the per share price and maintain compliance with Nasdaq's minimum bid price requirement. After the split, every 20 shares will combine into 1 share, reducing the total outstanding shares from 23,587,400 to approximately 1,179,371. Fractional shares will be rounded up. The stock will cont...

    05-06 12:00

  • 美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元;Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价

    今日重点评级关注:Piper Sandler:维持Aclaris Therapeutics"超配"评级,目标价从7美元升至11美元;Evercore ISI集团:维持BioMarin Pharmaceutical"跑赢大市"评级,目标价从110美元升至120美元

    05-06 11:29

  • Climb Announces North American Distribution Partnership with Dashlane

    Climb, a global specialty technology distributor, has announced a new North American distribution partnership with Dashlane, a leader in credential security. Through this collaboration, Climb will expand access to Dashlane’s Omnix platform for U.S. and Canadian partners, addressing the critical issue of stolen and compromised credentials. Dashlane’s Omnix platform goes beyond traditional password management to proactively protect employee logins ...

    05-06 11:00

  • MannKind Announces Ralinepag Dry Powder Inhalation (DPI) Program to be Pursued for Pulmonary Hypertension and Fibrotic Lung Diseases

    MannKind and United Therapeutics are collaborating to develop a dry powder inhalation (DPI) formulation of ralinepag (MNKD-1501) for pulmonary arterial hypertension (PAH). United Therapeutics has made a $5 million payment to MannKind and plans to be the primary manufacturer. MannKind is eligible for up to $35 million in milestones and 10% royalties. Ralinepag DPI is expected to support once-daily dosing and is in early development stages. United ...

    05-06 10:30